09:11 AM EST, 02/27/2025 (MT Newswires) -- Novavax ( NVAX ) reported a Q4 net loss Thursday of $0.51 per diluted share, narrower than a loss of $1.44 a year earlier.
Analysts polled by FactSet expected a loss of $0.51.
Revenue for the quarter ended Dec. 31 was $88.3 million, down from $291.3 million a year earlier.
Analysts surveyed by FactSet expected $84.4 million.